[1]
Siasos G, Tsigkou V, Bletsa E, et al. Antithrombotic treatment in coronary artery disease. Curr Pharm Des 2023; 29(35): 2764-79.
[2]
Tsioufis PA, Theofilis P, Vlachakis PK, et al. Novel invasive methods as the third pillar for the treatment of essential uncontrolled hypertension. Curr Pharm Des 2023; 29(35): 2780-6.
Current Pharmaceutical Design
Title:Contemporary Management of Risk Factors in Coronary Artery Disease (Part 2)
Volume: 29 Issue: 35
Author(s): Dimitris Tousoulis and Panagiotis Theofilis
Affiliation:
Export Options
About this article
Cite this article as:
Tousoulis Dimitris and Theofilis Panagiotis, Contemporary Management of Risk Factors in Coronary Artery Disease (Part 2), Current Pharmaceutical Design 2023; 29 (35) . https://dx.doi.org/10.2174/138161282935231207112504
DOI https://dx.doi.org/10.2174/138161282935231207112504 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements